Objectives: To evaluate putative anti-staphylococcal biofilm antibiotic combinations used in the management of periprosthetic joint infections (PJIs).
Introduction
Antibiotics remain an important adjunct to surgical debridement in the management of orthopaedic biofilm-related infections such as prosthetic joint infection (PJI) 1 and infected fracture non-union. 2 Currently the central tenets of this approach are to: first, identify the relevant organisms causing the infection; second, determine how susceptible they are to a wide spectrum of antibiotics; and third, select an antibiotic that is able to be pharmacokinetically delivered, at a concentration that is pharmacodynamically (PD) effective whilst maintaining an acceptable side effect profile. The most important treatment of PJI is surgical debridement in an attempt to eradicate the bacterial biofilm, 3 but the opportunity to administer antibiotics locally remains an important adjunct. The rationale of local antibiotic delivery is to enhance local antibiotic soft tissue concentration in order to eradicate the remaining biofilm and prevent recolonization. This depot is not dependent on the presence of vascularized tissues and achieves concentrations that are orders of magnitude higher than systemic administration would be able to safely deliver. Despite the availability of biodegradable systems, antibiotic-loaded acrylic bone cement (ALAC) remains the most commonly used antibiotic carrier in the management of PJI. There is evidence to show that ALAC is effective in minimizing the risk of PJI following primary hip and knee replacement. [4] [5] [6] The use of locally delivered antibiotics in the management of PJI has been shown to be associated with eradication of infection in 75%-91% of cases. 7, 8 There is, however, a paucity of evidence on whether local delivery of a single agent or a combination is superior. The antibiotics commonly used in the management of PJI 9 are listed in Table 1 . It is recognized that exposure to sub-inhibitory levels of one antibiotic can select for high-level tolerance to multiple and dissimilar antibiotics. 10 It is feasible that even very high concentrations remain ineffective against sessile biofilm organisms and persister cells, which are tolerant to a variety of stresses. 11 Persister cells are a dormant, non-dividing sub-population of cells found within biofilms that remain viable irrespective of the concentration of the antibiotic. When the concentration of antibiotic reduces, persisters are thought to repopulate the biofilm, which will shed new planktonic cells, producing the relapsing biofilm infection seen clinically. 12 Antibiotic combinations are thought to work by: broadening the spectrum of antibiotic activity in empirical therapy; utilizing synergistic effects of combinations; preventing resistance mechanisms from evolving; enhancing intracellular penetration; and limiting the effects of bacterial toxins and expression of other virulence factors. 13, 14 Several commercial bone cements have been designed for treating PJI, which contain gentamicin, with either clindamycin (Refobacin Revision
. 15, 16 Meta-analyses of clinical trials evaluating antibiotic combinations in periprosthetic joint infection have concluded that the patient populations and treatment algorithms were too heterogeneous to draw any clinically useful inferences about the optimal antibiotic regimen from the available data. 17, 18 In lieu of good-quality clinical evidence, inferences about the optimal antibiotic dose or combination for therapy must be made with in vitro experiments and with animal models before a properly controlled trial comparing the most promising candidate is commissioned. This study aimed to investigate which common clinically used antibiotic combinations, at clinically achievable concentrations, were effective against Staphylococcus biofilms.
Materials and methods

Bacterial strains and media
The following bacterial strains were used: an MSSA reference strain (ATCC 29213, MSSA-N), which has been extensively studied in its biofilm state; [19] [20] [21] and a coagulase-negative Staphylococcus (CNS-J) isolated from an infected hip replacement. Bacterial strains were cultured aerobically in LB overnight at 37 C prior to use. The LB used in this study was: Bacto tryptone (Difco) (10 g), Bacto yeast extract (Difco) (5 g) and NaCl (10 g), dissolved up to 1 L of distilled H 2 O. The LB was solidified by adding 15 g/L agar (Difco) prior to autoclaving. Unexpected antibiotic activity in biofilms
JAC
Antibiotics
The following antibiotics were used in this study: linezolid 2000 mg/L (Zyvox V R ; Pharmacia, Sandwich, Kent, UK), gentamicin 4000 mg/L (Cidomycin V R ; Sanofi Aventis, Guildford, UK), rifampicin 400 mg/L (Rifadin V R ; Sanofi Aventis, Guildford, UK), ciprofloxacin 2000 mg/L (PLIVA Pharma Ltd, Petersfield, UK), vancomycin 4000 mg/L (Wockhardt UK Limited, Wrexham, UK), clindamycin 4000 mg/L (Cleocin V R ; Sanofi Aventis, Guildford, UK) and daptomycin 4000 mg/L (Cubicin V R ; Cubist Pharmaceuticals, Lexington, USA). All were stored and prepared per the manufacturer's instructions prior to use. 22 Daptomycin was supplemented with 50 mg/L Ca 2! , as it has been shown to result in a more amphiphilic and bactericidal compound, 23, 24 improving in vitro activity. 25 The antibiotics examined in this study reflected the most commonly used agents in current clinical practice.
4,26-28
Dissolvable bead biofilm assay
The dissolvable bead biofilm assay was performed, as previously described, 29 in order to determine the minimum biofilm eradication concentration (MBEC) of each antimicrobial and antimicrobial combination. The MBEC is defined as the lowest concentration of antimicrobial that eradicates 99.9% of the bacteria in a biofilm state compared with growth controls in the same conditions. 30, 31 The 24 h bacterial biofilms grown on the surface of the alginate beads were exposed to the test antimicrobials, dissolved in LB, for 3 h to obtain an eradication curve. Following treatment the beads were washed in sterile water and then dissolved using a sterile 0.05 M Na 2 CO 3 and 0.02 M citric acid (pH 6.8) solution. The liberated organisms then underwent serial dilution and were plated onto LB agar using the Miles-Misra technique. 32 Each test condition was performed using three biological replicates, with each replicate undergoing three technical repeats.
Data handling, graphical illustration and statistical analysis
Data were analysed using GraphPad Prism 6 for Mac OS X software (GraphPad Software, San Diego, CA, USA, www.graphpad.com) for statistical analysis and graphing.
Results
Antibiotic activity against Staphylococcus biofilms
In order to investigate whether a single antimicrobial would be effective at eradicating Staphylococcus biofilms, their effects were examined at concentrations between 4 and 2048 mg/L. The MBEC was established for each antibiotic tested (Figures 1 and 2 ).
Figures 1 and 2 demonstrate that only gentamicin and daptomycin were observed to be effective bactericidal agents at clinically achievable concentrations. Rifampicin, clindamycin, linezolid, vancomycin and ciprofloxacin did not reduce cell viability substantially over the 3 h exposure despite being orders of magnitude above typical minimal bactericidal concentrations for planktonic staphylococci. 22 
Antibiotic activity of antibiotic combinations delivered locally in PJI
To investigate which combinations were efficacious in treating Staphylococcus biofilms, five antibiotics suitable for local delivery were tested in combinations of two or three. The concentration at which they are eluted in vivo from ALAC varies significantly and is dependent on cement porosity, 33 hydrophilia of the polymethylmethacrylate structure, volume of distribution, 34, 35 the surface area of the cement, the assay used to measure elution, and the physical state and chemical structure of the antibiotic. 36 Following a review of relevant in vitro 15, 27, 35, [37] [38] [39] [40] [41] [42] [43] [44] [45] and in vivo studies, 23,38,39,41,46-52 a concentration of 128 mg/L was chosen for the antibiotics commonly used in combination with gentamicin in ALACs to reflect the midrange between the high initial interfacial gap levels and the human in vivo levels recorded from sites more distant from the cement, such as seroma. From the data shown in Figures 3 and 4 , combinations of gentamicin and either ciprofloxacin or vancomycin, each at 128 mg/L, eradicated the biofilms of both isolates but combining ciprofloxacin and vancomycin together did not. Interestingly, despite both strains being susceptible to 128 mg/L gentamicin when Dall et al.
tested alone (Figures 1 and 2 ), the combination of clindamycin or linezolid with gentamicin appeared to reduce its bactericidal effect markedly ( Figure 3 ).
Antibiotic activity of antibiotic combinations in PJI delivered locally and systemically
As some antibiotics cannot be delivered locally because of practical or safety issues, they are administered systemically in addition to the antibiotics delivered locally. Further experiments were undertaken to model the effect of systemic doses of rifampicin or daptomycin administered as part of a therapeutic combination. The dissolving bead assay was repeated in triplicate with rifampicin at 4 mg/L and daptomycin between 4 and 16 mg/L to reflect the concentrations achieved by systemic delivery. 49, 51, 52 The other five antibiotics had a final concentration of 128 mg/L.
From Figures 5 and 6 it can be seen that a similar trend was observed in both strains, with a 3 log reduction seen in gentamicin/ daptomycin combinations. Whilst the addition of ciprofloxacin or vancomycin to gentamicin/daptomycin had little effect, clindamycin appeared to be antagonistic towards gentamicin/daptomycin. Similarly, despite both strains being susceptible to 128 mg/L of gentamicin when tested alone (Figures 1 and 2 ), the addition of clindamycin or rifampicin to the combination reduced its bactericidal effect markedly.
Gentamicin activity against Staphylococcus biofilms when used in combination
The results in Figures 3-6 were unexpected and potentially clinically relevant, as any antagonism may raise the MBEC above levels that are clinically achievable, leading to treatment failure. Another 
Fractional biofilm eradication concentration index
In order to quantify the apparent interactions seen and enable comparisons with previous and future work, the fractional biofilm eradication concentration (FBEC) index was calculated for gentamicin when used in each antibiotic combination. The FBEC is a modification of the fractional inhibitory concentration (FIC) index, 53 which is a method used to detect synergism or antagonism between two antibiotics. The data displayed in Figures 7 and 8 were analysed together with those in Figures 2 and 3 to calculate the FBEC index ( Table 2 ). Calculation of the FBEC for gentamicin is shown below: Dall et al. An FBEC index of 0.5 indicates a synergistic effect, .0.5 to 4.0 no interaction and .4.0 an antagonistic effect. 54 
Discussion
This study found that gentamicin and daptomycin were the only effective single-agent antibiotics, when used at clinically achievable doses, against coagulase-positive or -negative Staphylococcus biofilms. Other antibiotics were ineffective either alone or in combination (Figures 3-6) . Combinations of bactericidal antibiotics (except daptomycin) with gentamicin conferred a synergistic effect, whilst the bacteriostatic antibiotics examined were found to antagonize gentamicin action.
The differences seen between the seven different antibiotics examined cannot be explained simply by the differences in their ability to penetrate the glycocalyx of the biofilm. Indeed, gentamicin, ciprofloxacin, 55 daptomycin, 56 rifampicin, 57 linezolid 58 and clindamycin 59 have all demonstrated good penetration into Staphylococcus biofilms whilst only vancomycin has been shown to be significantly hampered by it. 55, 58 While gentamicin and daptomycin have different mechanisms of action, both impact membrane integrity, 56, [60] [61] [62] suggesting this may be an important aspect of the antistaphylococcal effect, including against MRSA. Although MRSA has been reported to have different mechanisms of biofilm formation from MSSA, 63 tolerance to non-penicillin antimicrobials in Staphylococcus aureus biofilms has been reported to be independent of the resistance mechanisms associated with MRSA strains. [64] [65] [66] [67] The lack of an agonistic effect seen with rifampicin combined with either vancomycin or ciprofloxacin is intriguing, as these combinations are commonly used in surgical practice with apparent success. 7 Olson et al., 68 who performed an in vitro study of CNS biofilms using steady-state antibiotics, also found that the addition of 12 mg/L rifampicin to 40 mg/L vancomycin did not result in additional killing. However, when repeating the experiment in a small animal model they reported the presence of a synergistic effect. In addition Zimmerli et al. 21 found the combination of rifampicin (trough 1 mg/L to peak 8 mg/L) and ciprofloxacin (trough 0.11 mg/L to peak 1 mg/L) or vancomycin (trough 3 mg/L to peak 9 mg/L) much more effective than monotherapy. A possible explanation for this discrepancy may be in the dosing regimens, which are constant in vitro but vary in vivo. Lewis 12 postulated that cyclic dosing that allowed persisters to start repopulating the biofilm just as they are exposed to another bactericidal wave may eventually result in their eradication. The effect of the host's immune system might also serve to enhance discrepancies between laboratory and clinical studies.
A synergistic effect against an S. aureus biofilm seen when combining bactericidal antibiotics with gentamicin has been previously reported by Tsuji and Ryback, 69 who also found gentamicin and daptomycin to be the most efficacious as single antibiotics whereas vancomycin was ineffective. However, the strong antagonism seen between gentamicin and linezolid, rifampicin and clindamycin has, to the authors' knowledge, not been observed before.
Previous studies have reported that in the presence of a subinhibitory concentration of DNA synthesis-inhibiting antibiotic, the addition of a protein synthesis inhibitor increases the steady-state growth rate of planktonic Escherichia coli and S. aureus cultures. 70, 71 Bollenbach et al. 72 reported that there is an optimal ratio between protein synthesis and DNA replication. They reported that when only one of these processes is hampered the subsequent inhibition of planktonic bacteria growth is greater than when both protein synthesis and DNA replication are impaired. 72 Therefore, many protein synthesis inhibitors and DNA synthesis inhibitors in combination could produce higher growth than just a single inhibitor by itself, leading to an antagonistic interaction. 73 There are two postulates for the observed antagonism. Either exposure to the additional antibiotics increased tolerance to gentamicin, or a chemical interaction between the two antibiotics rendered both less active. Given that the effect was observed with narrow interquartile ranges in three antibiotics for which interactions have not been published before, the development of tolerance seems more likely. Staphylococci have a diverse network of regulators that modify gene expression and enable them to tolerate a wide range of environmental stresses, which include antibiotics and cationic antimicrobial peptides (CAMPs). They are able to alter the proportion of the negatively charged polysaccharide intercellular adhesin and positively charged teichoic acids in their extracellular polymeric matrix and cell membrane via the GraRS system. 74 These modifications can confer significant tolerance to positively charged CAMPs and antimicrobials such as gentamicin, vancomycin and daptomycin. 75, 76 Although the envelope stress response has been previously found not to be induced by gentamicin, vancomycin or daptomycin, 77 the effect of bacteriostatic antibiotics is unknown.
Recent efforts to augment the cellular uptake of gentamicin, either by degrading the integrity of the cell membrane or increasing the proton motive force have been described. 78 CAMPs are normally produced as part of the host's response but can be isolated from non-pathogenic bacteria and have been shown to be synergistic with gentamicin against S. aureus at clinically achievable doses. 78 CAMPs form complexes with the lipids in the cell membrane resulting in poration, allowing gentamicin to enter the cell. 79 Both aminoglycoside uptake 80 and hydroxyl radical formation by bactericidal agents 62 are energy dependent via the proton motive force. It may be that bacteriostatic antibiotics lead to a reduction in metabolic activity, leading to reduced gentamicin uptake and subsequent oxidative damage. Kohanski et al. 81 postulated that the common final pathway for all bactericidal drugs is overwhelming oxidative damage from hydroxyl radical formation. While bacteriostatic drugs do not cause oxidative stresses, their effects may deplete the pool of redox-active metabolic intermediates such as NAD(H).
It has been previously reported that combinations of gentamicin and clindamycin are synergistic in the inhibition of staphylococcal biofilm formation. Neut et al. 82 reported that the presence of clindamycin (or fusidic acid) in gentamicin ALAC had no influence on the elution dynamics of gentamicin, but the authors also concluded that the combinations of gentamicin and clindamycin or fusidic acid are more effective in preventing in vitro biofilm Unexpected antibiotic activity in biofilms JAC formation than bone cements with gentamicin as a single drug. 82 A further study conducted by Ensing et al. 83 reported similar results with greater growth inhibition associated with gentamicin/clindamycin ALAC compared with gentamicin ALAC alone. However, the gentamicin/clindamycin ALAC contained double the starting amount of gentamicin found in the mono-antimicrobial ALAC. In addition the combination ALAC not only released a greater amount of gentamicin overall but did so at a faster rate throughout the treatment period. It would seem reasonable that this higher dose of gentamicin released from the combination ALAC would explain these findings.
As this study focused on short antibiotic exposures, mimicking the first few hours of treatment, longer time courses of exposure may reveal different effects. 66 However, there is consensus that the initial 48 h postoperatively are the most important to prevent recolonization and biofilm formation. It has been shown that the very high concentrations that are seen initially in vivo trail off rapidly, and unless dosing is consistent with in vivo pharmacokinetics, then this short exposure time is a reasonable estimate of the in vivo effects. A further limitation was that only a partial chequerboard analysis could be performed owing to limited resources.
This study is the first to describe the antagonistic effect of bacteriostatic antibiotics on gentamicin action against both coagulase-positive and -negative Staphylococcus biofilms. There remains an urgent clinical need to optimize the management of staphylococcal PJI by establishing the most efficacious antimicrobial regimen to complement surgical debridement. Gentamicin and daptomycin were found to be the only effective single-agent antibiotics, when used at clinically achievable locally delivered concentrations, against Staphylococcus biofilms. Interestingly, the addition of a bacteriostatic antibiotic, at commonly used concentrations, was found to antagonize the ability of gentamicin to eradicate Staphylococcus biofilms. Further investigation of these findings may be useful in evaluating optimal use of antibiotic combinations in the management of PJI.
